株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心房細動治療薬の世界市場:成長動向・競合分析 2018年~2025年

Global Atrial Fibrillation Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025

発行 QYResearch 商品コード 709657
出版日 ページ情報 英文 123 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.83円で換算しております。
心房細動治療薬の世界市場:成長動向・競合分析 2018年~2025年 Global Atrial Fibrillation Drugs Industry Research Report, Growth Trends and Competitive Analysis 2018-2025
出版日: 2018年09月25日 ページ情報: 英文 123 Pages
概要

当レポートでは、世界の心房細動治療薬の市場を調査し、市場および薬剤の概要、販売量・収益・価格などの推移と予測、タイプ・用途・地域別の内訳、市場成長への各種影響因子の分析、競合環境と市場シェア、主要製造業者のプロファイルなどをまとめています。

第1章 レポート概要

  • 調査範囲
  • 調査対象製造業者
  • 市場区分:タイプ別
    • 抗不整脈薬
    • 抗凝固薬
  • 市場区分:用途別
    • 発作性心房細動
    • 持続性心房細動
    • 長期持続性心房細動
  • 調査対象
  • 調査対象年

第2章 世界の成長動向

  • 収益・販売量の分析
  • 収益・販売量の分析:地域別
  • 産業動向

第3章 製造業者の市場シェア

  • 販売量・市場シェアの推移:製造業者別
  • 収益・市場シェアの推移:製造業者別
  • 価格:製造業者別
  • 主要製造業者の工場の分布・販売エリア
  • 主要製造業者の市場参入時期
  • 主要製造業者の提供製品
  • M&A・拡張計画

第4章 市場規模の推移:タイプ別

  • 販売量のシェア
  • 収益のシェア
  • 価格

第5章 市場規模の推移:用途別

  • 概要
  • 販売量

第6章 北米市場の分析

  • 市場分析:企業別
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 市場分析:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州市場の分析

  • 市場分析:企業別
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 市場分析:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋市場の分析

  • 市場分析:企業別
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 市場分析:国別
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • インドネシア
    • マレーシア
    • フィリピン
    • タイ
    • ベトナム

第9章 中南米市場の分析

  • 市場分析:企業別
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 市場分析:国別
    • ブラジル

第10章 中東・アフリカ市場の分析

  • 市場分析:企業別
  • 市場分析:タイプ別
  • 市場分析:用途別
  • 市場分析:国別
    • GCC諸国
    • エジプト
    • 南アフリカ

第11章 企業プロファイル

  • Boehringer Ingelheim
  • Janssen Pharmaceuticals
  • Sanofi
  • ARCA Biopharma
  • Armetheon
  • Baxter
  • Bristol-Myers Squibb
  • ChanRx
  • 第一三共
  • Gilead Sciences
  • HUYA Biosciences
  • Menarini
  • Pfizer

第12章 バリューチェーン・販売経路

第13章 市場予測

  • 販売量・収益の予測
  • 販売量の予測:タイプ別
  • 販売量の予測:用途別
  • 販売量の予測:地域別

第14章 調査結果・総論

第15章 付録

図表

List of Tables and Figures

  • Figure Atrial Fibrillation Drugs Product Picture
  • Table Atrial Fibrillation Drugs Key Market Segments
  • Table Major Manufacturers Atrial Fibrillation Drugs Covered in This Report
  • Table Global Atrial Fibrillation Drugs Market Size Growth Rate by Type 2018-2025 (K Pcs) & (Million US$)
  • Figure Global Atrial Fibrillation Drugs Sales Market Shar by Type 2013-2025
  • Figure Anti-Arrhythmic Drugs Figures
  • Table Global Atrial Fibrillation Drugs Market Share by Application 2018-2025 (K Pcs)
  • Figure Atrial Fibrillation Drugs Report Years Considered
  • Figure Global Atrial Fibrillation Drugs Market Size 2013-2025 (Million US$)
  • Figure Global Atrial Fibrillation Drugs Sales 2013-2018 (K Pcs)
  • Table Global Atrial Fibrillation Drugs Market Size by Regions 2013-2018 (K Pcs) & (Million US$)
  • Table Global Atrial Fibrillation Drugs Sales by Regions 2013-2018 (K Pcs)
  • Table Global Atrial Fibrillation Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Atrial Fibrillation Drugs Sales Market Share by Regions 2013-2018
  • Figure Global Atrial Fibrillation Drugs Sales Market Share by Regions in 2018
  • Table Global Atrial Fibrillation Drugs Revenue by Regions 2013-2018 (Million US$)
  • Table Global Atrial Fibrillation Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Atrial Fibrillation Drugs Revenue Market Share by Regions 2013-2018
  • Figure Global Atrial Fibrillation Drugs Revenue Market Share by Regions in 2018
  • Table Market Top Trends
  • Table Global Atrial Fibrillation Drugs Sales by Manufacturers (2013-2018) (K Pcs)
  • Table Global Atrial Fibrillation Drugs Sales Share by Manufacturers (2013-2018)
  • Figure Global Atrial Fibrillation Drugs Sales Share by Manufacturers in 2018
  • Table Atrial Fibrillation Drugs Revenue by Manufacturers (2013-2018) (Million USD)
  • Table Atrial Fibrillation Drugs Revenue Share by Manufacturers (2013-2018)
  • Figure Atrial Fibrillation Drugs Value Share by Manufacturers in 2018
  • Table Global Atrial Fibrillation Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Manufacturers Atrial Fibrillation Drugs Price (2013-2018) (USD/Pcs)
  • Table Key Manufacturers Atrial Fibrillation Drugs Plants/Factories Distribution
  • Table Key Manufacturers Atrial Fibrillation Drugs Area Served
  • Table Date of Key Manufacturers Enter into Atrial Fibrillation Drugs Market
  • Table Key Manufacturers Atrial Fibrillation Drugs Product Type
  • Table Global Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table Global Atrial Fibrillation Drugs Sales Share by Type (2013-2018)
  • Figure Global Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure Global Atrial Fibrillation Drugs Sales Market Share by Type in 2017
  • Table Global Atrial Fibrillation Drugs Revenue by Type (2013-2018) (Million US$)
  • Table Global Atrial Fibrillation Drugs Revenue Share by Type (2013-2018)
  • Figure Global Atrial Fibrillation Drugs Revenue Market Share by Type (2013-2018)
  • Figure Global Atrial Fibrillation Drugs Revenue Market Share by Type in 2017
  • Table Atrial Fibrillation Drugs Price by Type 2013-2018 (USD/Pcs)
  • Table Global Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table Global Atrial Fibrillation Drugs Sales Share by Application (2013-2018)
  • Figure Global Sales Atrial Fibrillation Drugs Market Share by Application (2013-2018)
  • Figure Global Sales Atrial Fibrillation Drugs Market Share by Application in 2017
  • Figure North America Atrial Fibrillation Drugs Sales Growth Rate 2013-2018 (K Pcs)
  • Figure North America Atrial Fibrillation Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table North America Atrial Fibrillation Drugs Sales by Company (2013-2018) (K Pcs)
  • Table North America Atrial Fibrillation Drugs Sales Market Share by Company (2013-2018)
  • Figure North America Atrial Fibrillation Drugs Sales Market Share by Company in 2018
  • Table North America Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table North America Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure North America Atrial Fibrillation Drugs Market Share by Type in 2018
  • Table North America Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table North America Atrial Fibrillation Drugs Sales Market Share by Application (2013-2018)
  • Figure North America Atrial Fibrillation Drugs Market Share by Application in 2018
  • Table North America Atrial Fibrillation Drugs Sales by Countries (2013-2018) (K Pcs)
  • Table North America Atrial Fibrillation Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 North America Atrial Fibrillation Drugs Sales Market Share by Countries
  • Table North America Atrial Fibrillation Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table North America Atrial Fibrillation Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 North America Atrial Fibrillation Drugs Revenue Market Share by Countries
  • Figure United States Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Canada Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Mexico Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Europe Atrial Fibrillation Drugs Sales Growth Rate 2013-2018 (K Pcs)
  • Figure Europe Atrial Fibrillation Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Europe Atrial Fibrillation Drugs Sales by Company (2013-2018) (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Market Share by Company (2013-2018)
  • Figure Europe Atrial Fibrillation Drugs Sales Market Share by Company in 2018
  • Table Europe Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Europe Atrial Fibrillation Drugs Market Share by Type
  • Table Europe Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Europe Atrial Fibrillation Drugs Market Share by Application
  • Table Europe Atrial Fibrillation Drugs Sales by Countries (2013-2018) (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Europe Atrial Fibrillation Drugs Sales Market Share by Countries
  • Table Europe Atrial Fibrillation Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Europe Atrial Fibrillation Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Europe Atrial Fibrillation Drugs Revenue Market Share by Countries in 2018
  • Figure Germany Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure France Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure UK Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Italy Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Russia Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Asia Pacific Atrial Fibrillation Drugs Sales Growth Rate 2013-2018 (K Pcs)
  • Figure Asia Pacific Atrial Fibrillation Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales by Company (2013-2018) (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Company (2013-2018)
  • Figure Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Company in 2018
  • Table Asia Pacific Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure Asia Pacific Atrial Fibrillation Drugs Market Share by Type in 2018
  • Table Asia Pacific Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Application (2013-2018)
  • Figure Asia Pacific Atrial Fibrillation Drugs Market Share by Application in 2018
  • Table Asia Pacific Atrial Fibrillation Drugs Sales by Countries (2013-2018) (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Atrial Fibrillation Drugs Sales Market Share by Countries
  • Table Asia Pacific Atrial Fibrillation Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Asia Pacific Atrial Fibrillation Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Asia Pacific Atrial Fibrillation Drugs Revenue Market Share by Countries
  • Figure China Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure China Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Japan Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Japan Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Korea Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Korea Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure India Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure India Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Australia Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Australia Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Indonesia Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Indonesia Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Malaysia Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Malaysia Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Philippines Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Philippines Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Thailand Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Thailand Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Vietnam Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Vietnam Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (Million US$)
  • Figure Central & South America Atrial Fibrillation Drugs Sales Growth Rate 2013-2018 (K Pcs)
  • Figure Central & South America Atrial Fibrillation Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Central & South America Atrial Fibrillation Drugs Sales by Company (2013-2018) (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Market Share by Company (2013-2018)
  • Figure Central & South America Atrial Fibrillation Drugs Sales Market Share by Company in 2018
  • Table Central & South America Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure Central & South America Atrial Fibrillation Drugs Market Share by Type in 2018
  • Table Central & South America Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Market Share by Application (2013-2018)
  • Figure Central & South America Atrial Fibrillation Drugs Market Share by Application in 2018
  • Table Central & South America Atrial Fibrillation Drugs Sales by Countries (2013-2018) (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Market Share by Countries (2013-2018)
  • Figure Central & South America Atrial Fibrillation Drugs Sales Market Share by Countries in 2018
  • Table Central & South America Atrial Fibrillation Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Central & South America Atrial Fibrillation Drugs Revenue Market Share by Countries (2013-2018)
  • Figure Central & South America Atrial Fibrillation Drugs Revenue Market Share by Countries in 2018
  • Figure Brazil Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Brazil Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (K Pcs)
  • Figure Middle East and Africa Atrial Fibrillation Drugs Sales Growth Rate 2013-2018 (K Pcs)
  • Figure Middle East and Africa Atrial Fibrillation Drugs Revenue Growth Rate 2013-2018 (Million US$)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales by Type (2013-2018) (K Pcs)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales Market Share by Type (2013-2018)
  • Figure 2017 Middle East and Africa Atrial Fibrillation Drugs Market Share by Type
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales by Application (2013-2018) (K Pcs)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales Market Share by Application (2013-2018)
  • Figure 2017 Middle East and Africa Atrial Fibrillation Drugs Market Share by Application
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales by Countries (2013-2018) (K Pcs)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Atrial Fibrillation Drugs Sales Market Share by Countries
  • Table Middle East and Africa Atrial Fibrillation Drugs Revenue by Countries (2013-2018) (Million US$)
  • Table Middle East and Africa Atrial Fibrillation Drugs Revenue Market Share by Countries (2013-2018)
  • Figure 2017 Middle East and Africa Atrial Fibrillation Drugs Revenue Market Share by Countries
  • Figure GCC Countries Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure GCC Countries Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (K Pcs)
  • Figure Egypt Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure Egypt Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (K Pcs)
  • Figure South Africa Atrial Fibrillation Drugs Sales Growth Rate (2013-2018) (K Pcs)
  • Figure South Africa Atrial Fibrillation Drugs Revenue Growth Rate (2013-2018) (K Pcs)
  • Table Boehringer Ingelheim Company Details
  • Table Boehringer Ingelheim Description and Business Overview
  • Table Boehringer Ingelheim Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Boehringer Ingelheim Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Boehringer Ingelheim Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Boehringer Ingelheim Recent Development
  • Table Janssen Pharmaceuticals Company Details
  • Table Janssen Pharmaceuticals Description and Business Overview
  • Table Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Janssen Pharmaceuticals Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Janssen Pharmaceuticals Recent Development
  • Table Sanofi Company Details
  • Table Sanofi Description and Business Overview
  • Table Sanofi Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Sanofi Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Sanofi Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Sanofi Recent Development
  • Table ARCA Biopharma Company Details
  • Table ARCA Biopharma Description and Business Overview
  • Table ARCA Biopharma Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table ARCA Biopharma Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table ARCA Biopharma Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table ARCA Biopharma Recent Development
  • Table Armetheon Company Details
  • Table Armetheon Description and Business Overview
  • Table Armetheon Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Armetheon Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Armetheon Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Armetheon Recent Development
  • Table Baxter Company Details
  • Table Baxter Description and Business Overview
  • Table Baxter Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Baxter Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Baxter Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Baxter Recent Development
  • Table Bristol-Myers Squibb Company Details
  • Table Bristol-Myers Squibb Description and Business Overview
  • Table Bristol-Myers Squibb Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Bristol-Myers Squibb Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Bristol-Myers Squibb Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Bristol-Myers Squibb Recent Development
  • Table ChanRx Company Details
  • Table ChanRx Description and Business Overview
  • Table ChanRx Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table ChanRx Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table ChanRx Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table ChanRx Recent Development
  • Table Daiichi Sankyo Company Details
  • Table Daiichi Sankyo Description and Business Overview
  • Table Daiichi Sankyo Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Daiichi Sankyo Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Daiichi Sankyo Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Daiichi Sankyo Recent Development
  • Table Gilead Sciences Company Details
  • Table Gilead Sciences Description and Business Overview
  • Table Gilead Sciences Atrial Fibrillation Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2013-2018)
  • Table Gilead Sciences Atrial Fibrillation Drugs Sales Growth Rate (2013-2018)
  • Table Gilead Sciences Atrial Fibrillation Drugs Sales Market Share in Global Market
  • Table Gilead Sciences Recent Development
  • Table HUYA Biosciences Company Details
  • Table Menarini Company Details
  • Table Pfizer Company Details
  • Figure Atrial Fibrillation Drugs Value Chain
  • Table Atrial Fibrillation Drugs Distributors List
  • Table Atrial Fibrillation Drugs Customers List
  • Table Global Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs) & (Million US$)
  • Figure Global Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Revenue Forecast 2018-2025 (Million US$)
  • Table Global Atrial Fibrillation Drugs Sales Forecast by Type 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Forecast by Type 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Market Share Forecast by Type 2018-2025
  • Table Global Atrial Fibrillation Drugs Sales Forecast by Application 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Forecast by Application 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Market Share Forecast by Application 2018-2025
  • Table Global Atrial Fibrillation Drugs Sales Forecast by Regions 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Forecast by Regions 2018-2025 (K Pcs)
  • Figure Global Atrial Fibrillation Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Global Atrial Fibrillation Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Atrial Fibrillation Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Figure Global Atrial Fibrillation Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Table North America Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025 (K Pcs)
  • Table North America Atrial Fibrillation Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table North America Atrial Fibrillation Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table North America Atrial Fibrillation Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure United States Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Canada Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure MexicoAtrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025 (K Pcs)
  • Table Europe Atrial Fibrillation Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Europe Atrial Fibrillation Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Europe Atrial Fibrillation Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Germany Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure France Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure UK Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Italy Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Russia Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025 (K Pcs)
  • Table Asia Pacific Atrial Fibrillation Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Asia Pacific Atrial Fibrillation Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Asia Pacific Atrial Fibrillation Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure China Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Japan Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Korea Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure India Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Australia Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Indonesia Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Thailand Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Malaysia Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Philippines Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Figure Vietnam Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025 (K Pcs)
  • Table Central & South America Atrial Fibrillation Drugs Sales Market Share Forecast by Countries 2018-2025
  • Table Central & South America Atrial Fibrillation Drugs Revenue Forecast by Countries 2018-2025 (Million US$)
  • Table Central & South America Atrial Fibrillation Drugs Revenue Market Share Forecast by Countries 2018-2025
  • Figure Brazil Atrial Fibrillation Drugs Sales Forecast 2018-2025 (K Pcs)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales Forecast by Regions 2018-2025 (K Pcs)
  • Table Middle East and Africa Atrial Fibrillation Drugs Sales Market Share Forecast by Regions 2018-2025
  • Table Middle East and Africa Atrial Fibrillation Drugs Revenue Forecast by Regions 2018-2025 (Million US$)
  • Table Middle East and Africa Atrial Fibrillation Drugs Revenue Market Share Forecast by Regions 2018-2025
  • Figure GCC Countries Atrial Fibrillation Drugs Sales Growth Rate (2016-2025) (K Pcs)
  • Figure Egypt Atrial Fibrillation Drugs Sales Growth Rate (2016-2025) (K Pcs)
  • Figure South Africa Atrial Fibrillation Drugs Sales Growth Rate (2016-2025) (K Pcs)
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
目次

This study researches the market size of Atrial Fibrillation Drugs, presents the global Atrial Fibrillation Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.

This report focuses on the key data information of Atrial Fibrillation Drugs in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Atrial Fibrillation Drugs for each region and countries in each region.

For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2018, the global Atrial Fibrillation Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Atrial Fibrillation Drugs.

This report includes the following manufacturers; we can also add the other companies as you want.

  • Boehringer Ingelheim
  • Janssen Pharmaceuticals
  • Sanofi
  • ARCA Biopharma
  • Armetheon
  • Baxter
  • Bristol-Myers Squibb
  • ChanRx
  • Daiichi Sankyo
  • Gilead Sciences
  • HUYA Biosciences
  • Menarini
  • Pfizer
  • Pierre Fabre
  • Servier
  • Xention

Market Segment by Product Type

  • Anti-Arrhythmic Drugs
  • Anti-Coagulant Drugs

Market Segment by Application

  • Paroxysmal Atrial Fibrillation
  • Persistent Atrial Fibrillation
  • Longstanding Persistent Afib

Market size split by Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Philippines
    • Thailand
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
    • Rest of Central & South America
  • Middle East & Africa
    • GCC Countries
    • Egypt
    • South Africa

The study objectives are:

  • To analyze and research the global Atrial Fibrillation Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
  • To present the key Atrial Fibrillation Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
  • To split the breakdown data by regions, type, companies and applications.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends, drivers, influence factors in global and regions.
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Atrial Fibrillation Drugs are as follows:

  • History Year: 2013-2018
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

Table of Contents

1. Report Overview

  • 1.1. Research Scope
  • 1.2. Major Manufacturers Covered in This Report
  • 1.3. Market Segment by Type
  • 1.4. Market Segment by Application
    • 1.4.1. Global Atrial Fibrillation Drugs Market Share by Application (2018-2025)
  • 1.5. Study Objectives
  • 1.6. Years Considered

2. Global Growth Trends

  • 2.1. Global Atrial Fibrillation Drugs Market Size
    • 2.1.1. Global Atrial Fibrillation Drugs Revenue 2013-2025
    • 2.1.2. Global Atrial Fibrillation Drugs Sales 2013-2025
  • 2.2. Atrial Fibrillation Drugs Growth Rate by Regions
    • 2.2.1. Global Atrial Fibrillation Drugs Sales by Regions 2013-2018
    • 2.2.2. Global Atrial Fibrillation Drugs Revenue by Regions 2013-2018
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers

3. Market Share by Manufacturers

  • 3.1. Atrial Fibrillation Drugs Sales by Manufacturers
    • 3.1.1. Atrial Fibrillation Drugs Sales by Manufacturers 2013-2018
    • 3.1.2. Atrial Fibrillation Drugs Sales Market Share by Manufacturers 2013-2018
  • 3.2. Revenue by Manufacturers
    • 3.2.1. Atrial Fibrillation Drugs Revenue by Manufacturers (2013-2018)
    • 3.2.2. Atrial Fibrillation Drugs Revenue Share by Manufacturers (2013-2018)
    • 3.2.3. Global Atrial Fibrillation Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.3. Atrial Fibrillation Drugs Price by Manufacturers
  • 3.4. Key Manufacturers Atrial Fibrillation Drugs Plants/Factories Distribution and Area Served
  • 3.5. Date of Key Manufacturers Enter into Atrial Fibrillation Drugs Market
  • 3.6. Key Manufacturers Atrial Fibrillation Drugs Product Offered
  • 3.7. Mergers & Acquisitions, Expansion Plans

4. Market Size by Type

  • 4.2. Global Atrial Fibrillation Drugs Sales Market Share by Type
  • 4.3. Global Atrial Fibrillation Drugs Revenue Market Share by Type
  • 4.4. Atrial Fibrillation Drugs Price by Type

5. Market Size by Application

  • 5.1. Overview
  • 5.2. Global Atrial Fibrillation Drugs Sales by Application

6. North America

  • 6.1. North America Atrial Fibrillation Drugs Breakdown Data by Company
  • 6.2. North America Atrial Fibrillation Drugs Breakdown Data by Type
  • 6.3. North America Atrial Fibrillation Drugs Breakdown Data by Application
  • 6.4. North America Atrial Fibrillation Drugs Breakdown Data by Countries
    • 6.4.1. North America Atrial Fibrillation Drugs Sales by Countries
    • 6.4.2. North America Atrial Fibrillation Drugs Revenue by Countries
    • 6.4.3. United States
    • 6.4.4. Canada
    • 6.4.5. Mexico

7. Europe

  • 7.1. Europe Atrial Fibrillation Drugs Breakdown Data by Company
  • 7.2. Europe Atrial Fibrillation Drugs Breakdown Data by Type
  • 7.3. Europe Atrial Fibrillation Drugs Breakdown Data by Application
  • 7.4. Europe Atrial Fibrillation Drugs Breakdown Data by Countries
    • 7.4.1. Europe Atrial Fibrillation Drugs Sales by Countries
    • 7.4.2. Europe Atrial Fibrillation Drugs Revenue by Countries
    • 7.4.3. Germany
    • 7.4.4. France
    • 7.4.5. UK
    • 7.4.6. Italy
    • 7.4.7. Russia

8. Asia Pacific

  • 8.1. Asia Pacific Atrial Fibrillation Drugs Breakdown Data by Company
  • 8.2. Asia Pacific Atrial Fibrillation Drugs Breakdown Data by Type
  • 8.3. Asia Pacific Atrial Fibrillation Drugs Breakdown Data by Application
  • 8.4. Asia Pacific Atrial Fibrillation Drugs Breakdown Data by Countries
    • 8.4.1. Asia Pacific Atrial Fibrillation Drugs Sales by Countries
    • 8.4.2. Asia Pacific Atrial Fibrillation Drugs Revenue by Countries
    • 8.4.3. China
    • 8.4.4. Japan
    • 8.4.5. Korea
    • 8.4.6. India
    • 8.4.7. Australia
    • 8.4.8. Indonesia
    • 8.4.9. Malaysia
    • 8.4.10. Philippines
    • 8.4.11. Thailand
    • 8.4.12. Vietnam

9. Central & South America

  • 9.1. Central & South America Atrial Fibrillation Drugs Breakdown Data by Company
  • 9.2. Central & South America Atrial Fibrillation Drugs Breakdown Data by Type
  • 9.3. Central & South America Atrial Fibrillation Drugs Breakdown Data by Application
  • 9.4. Central & South America Atrial Fibrillation Drugs Breakdown Data by Countries
    • 9.4.1. Central & South America Atrial Fibrillation Drugs Sales by Countries
    • 9.4.2. Central & South America Atrial Fibrillation Drugs Revenue by Countries
    • 9.4.3. Brazil

10. Middle East and Africa

  • 10.1. Middle East and Africa Atrial Fibrillation Drugs Breakdown Data by Type
  • 10.2. Middle East and Africa Atrial Fibrillation Drugs Breakdown Data by Application
  • 10.3. Middle East and Africa Atrial Fibrillation Drugs Breakdown Data by Countries
    • 10.3.1. Middle East and Africa Atrial Fibrillation Drugs Sales by Countries
    • 10.3.2. Middle East and Africa Atrial Fibrillation Drugs Revenue by Countries
    • 10.3.3. GCC Countries
    • 10.3.4. Egypt
    • 10.3.5. South Africa

11. Company Profiles

  • 11.1. Boehringer Ingelheim
    • 11.1.1. Boehringer Ingelheim Company Details
    • 11.1.2. Company Description and Business Overview
    • 11.1.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.1.4. Atrial Fibrillation Drugs Product Introduction
    • 11.1.5. Boehringer Ingelheim Recent Development
  • 11.2. Janssen Pharmaceuticals
    • 11.2.1. Janssen Pharmaceuticals Company Details
    • 11.2.2. Company Description and Business Overview
    • 11.2.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.2.4. Atrial Fibrillation Drugs Product Introduction
    • 11.2.5. Janssen Pharmaceuticals Recent Development
  • 11.3. Sanofi
    • 11.3.1. Sanofi Company Details
    • 11.3.2. Company Description and Business Overview
    • 11.3.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.3.4. Atrial Fibrillation Drugs Product Introduction
    • 11.3.5. Sanofi Recent Development
  • 11.4. ARCA Biopharma
    • 11.4.1. ARCA Biopharma Company Details
    • 11.4.2. Company Description and Business Overview
    • 11.4.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.4.4. Atrial Fibrillation Drugs Product Introduction
    • 11.4.5. ARCA Biopharma Recent Development
  • 11.5. Armetheon
    • 11.5.1. Armetheon Company Details
    • 11.5.2. Company Description and Business Overview
    • 11.5.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.5.4. Atrial Fibrillation Drugs Product Introduction
    • 11.5.5. Armetheon Recent Development
  • 11.6. Baxter
    • 11.6.1. Baxter Company Details
    • 11.6.2. Company Description and Business Overview
    • 11.6.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.6.4. Atrial Fibrillation Drugs Product Introduction
    • 11.6.5. Baxter Recent Development
  • 11.7. Bristol-Myers Squibb
    • 11.7.1. Bristol-Myers Squibb Company Details
    • 11.7.2. Company Description and Business Overview
    • 11.7.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.7.4. Atrial Fibrillation Drugs Product Introduction
    • 11.7.5. Bristol-Myers Squibb Recent Development
  • 11.8. ChanRx
    • 11.8.1. ChanRx Company Details
    • 11.8.2. Company Description and Business Overview
    • 11.8.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.8.4. Atrial Fibrillation Drugs Product Introduction
    • 11.8.5. ChanRx Recent Development
  • 11.9. Daiichi Sankyo
    • 11.9.1. Daiichi Sankyo Company Details
    • 11.9.2. Company Description and Business Overview
    • 11.9.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.9.4. Atrial Fibrillation Drugs Product Introduction
    • 11.9.5. Daiichi Sankyo Recent Development
  • 11.10. Gilead Sciences
    • 11.10.1. Gilead Sciences Company Details
    • 11.10.2. Company Description and Business Overview
    • 11.10.3. Sales, Revenue and Market Share of Atrial Fibrillation Drugs
    • 11.10.4. Atrial Fibrillation Drugs Product Introduction
    • 11.10.5. Gilead Sciences Recent Development
  • 11.11. HUYA Biosciences
  • 11.12. Menarini
  • 11.13. Pfizer

12. Value Chain and Sales Channels Analysis

  • 12.1. Value Chain Analysis
  • 12.2. Sales Channels Analysis
    • 12.2.1. Atrial Fibrillation Drugs Sales Channels
    • 12.2.2. Atrial Fibrillation Drugs Distributors
  • 12.3. Atrial Fibrillation Drugs Customers

13. Market Forecast

  • 13.1. Global Atrial Fibrillation Drugs Sales and Revenue Forecast 2018-2025
  • 13.2. Global Atrial Fibrillation Drugs Sales Forecast by Type
  • 13.3. Global Atrial Fibrillation Drugs Sales Forecast by Application
  • 13.4. Atrial Fibrillation Drugs Forecast by Regions
    • 13.4.1. Global Atrial Fibrillation Drugs Sales Forecast by Regions 2018-2025
    • 13.4.2. Global Atrial Fibrillation Drugs Revenue Forecast by Regions 2018-2025
  • 13.5. North America Market Forecast
    • 13.5.1. North America Atrial Fibrillation Drugs Forecast by Countries 2018-2025
    • 13.5.2. United States
    • 13.5.3. Canada
    • 13.5.4. Mexico
  • 13.6. Europe Market Forecast
    • 13.6.1. Europe Atrial Fibrillation Drugs Forecast by Countries 2018-2025
    • 13.6.2. Germany
    • 13.6.3. France
    • 13.6.4. UK
    • 13.6.5. Italy
    • 13.6.6. Russia
  • 13.7. Asia Pacific Market Forecast
    • 13.7.1. Asia Pacific Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025
    • 13.7.2. China
    • 13.7.3. Japan
    • 13.7.4. Korea
    • 13.7.5. India
    • 13.7.6. Australia
    • 13.7.7. Indonesia
    • 13.7.8. Thailand
    • 13.7.9. Malaysia
    • 13.7.10. Philippines
    • 13.7.11. Vietnam
  • 13.8. Central & South America Market Forecast
    • 13.8.1. Central & South America Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025
    • 13.8.2. Brazil
  • 13.9. Middle East and Africa Market Forecast
    • 13.9.1. Middle East and Africa Atrial Fibrillation Drugs Sales Forecast by Countries 2018-2025
    • 13.9.2. GCC Countries
    • 13.9.3. Egypt
    • 13.9.4. South Africa

14. Research Findings and Conclusion

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 15.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 13.1.2.2. Primary Sources
  • 15.2. Author Details
  • 15.3. Disclaimer